232 related articles for article (PubMed ID: 31139686)
21. Subclinical MRI disease activity influences cognitive performance in MS patients.
Damasceno A; Damasceno BP; Cendes F
Mult Scler Relat Disord; 2015 Mar; 4(2):137-43. PubMed ID: 25787189
[TBL] [Abstract][Full Text] [Related]
22. Corpus callosum index and long-term disability in multiple sclerosis patients.
Yaldizli O; Atefy R; Gass A; Sturm D; Glassl S; Tettenborn B; Putzki N
J Neurol; 2010 Aug; 257(8):1256-64. PubMed ID: 20198382
[TBL] [Abstract][Full Text] [Related]
23. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.
Has Silemek AC; Fischer L; Pöttgen J; Penner IK; Engel AK; Heesen C; Gold SM; Stellmann JP
Neuroimage Clin; 2020; 25():102177. PubMed ID: 32014828
[TBL] [Abstract][Full Text] [Related]
24. Deep Learning Corpus Callosum Segmentation as a Neurodegenerative Marker in Multiple Sclerosis.
Platten M; Brusini I; Andersson O; Ouellette R; Piehl F; Wang C; Granberg T
J Neuroimaging; 2021 May; 31(3):493-500. PubMed ID: 33587820
[TBL] [Abstract][Full Text] [Related]
25. Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging.
Vavasour IM; Sun P; Graf C; Yik JT; Kolind SH; Li DK; Tam R; Sayao AL; Schabas A; Devonshire V; Carruthers R; Traboulsee A; Moore GW; Song SK; Laule C
Mult Scler; 2022 Mar; 28(3):418-428. PubMed ID: 34132126
[TBL] [Abstract][Full Text] [Related]
26. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
[TBL] [Abstract][Full Text] [Related]
27. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
Rahmanzadeh R; Lu PJ; Barakovic M; Weigel M; Maggi P; Nguyen TD; Schiavi S; Daducci A; La Rosa F; Schaedelin S; Absinta M; Reich DS; Sati P; Wang Y; Bach Cuadra M; Radue EW; Kuhle J; Kappos L; Granziera C
Brain; 2021 Jul; 144(6):1684-1696. PubMed ID: 33693571
[TBL] [Abstract][Full Text] [Related]
28. Corpus callosum damage predicts disability progression and cognitive dysfunction in primary-progressive MS after five years.
Bodini B; Cercignani M; Khaleeli Z; Miller DH; Ron M; Penny S; Thompson AJ; Ciccarelli O
Hum Brain Mapp; 2013 May; 34(5):1163-72. PubMed ID: 22328451
[TBL] [Abstract][Full Text] [Related]
29. Non-lesional white matter changes depicted by q-space diffusional MRI correlate with clinical disabilities in multiple sclerosis.
Motegi H; Kufukihara K; Kitagawa S; Sekiguchi K; Hata J; Fujiwara H; Jinzaki M; Okano H; Nakamura M; Iguchi Y; Nakahara J
J Neurol Sci; 2024 Jan; 456():122851. PubMed ID: 38181653
[TBL] [Abstract][Full Text] [Related]
30. Diffusion basis spectrum imaging provides insights into MS pathology.
Sun P; George A; Perantie DC; Trinkaus K; Ye Z; Naismith RT; Song SK; Cross AH
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31871296
[TBL] [Abstract][Full Text] [Related]
31. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis.
Schiavi S; Petracca M; Sun P; Fleysher L; Cocozza S; El Mendili MM; Signori A; Babb JS; Podranski K; Song SK; Inglese M
Brain; 2021 Feb; 144(1):213-223. PubMed ID: 33253366
[TBL] [Abstract][Full Text] [Related]
33. Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis.
Lowe MJ; Horenstein C; Hirsch JG; Marrie RA; Stone L; Bhattacharyya PK; Gass A; Phillips MD
Neuroimage; 2006 Sep; 32(3):1127-33. PubMed ID: 16798013
[TBL] [Abstract][Full Text] [Related]
34. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
35. Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.
Gonçalves LI; Dos Passos GR; Conzatti LP; Burger JLP; Tomasi GH; Zandoná MÉ; Azambuja LS; Gomes I; Franco A; Sato DK; Becker J
Mult Scler Relat Disord; 2018 Feb; 20():154-158. PubMed ID: 29414290
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging.
Oh J; Henry RG; Genain C; Nelson SJ; Pelletier D
J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1281-6. PubMed ID: 15314115
[TBL] [Abstract][Full Text] [Related]
37. Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging.
Ge Y; Law M; Johnson G; Herbert J; Babb JS; Mannon LJ; Grossman RI
J Magn Reson Imaging; 2004 Jul; 20(1):1-7. PubMed ID: 15221802
[TBL] [Abstract][Full Text] [Related]
38. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis.
Abel S; Vavasour I; Lee LE; Johnson P; Ristow S; Ackermans N; Chan J; Cross H; Laule C; Dvorak A; Schabas A; Hernández-Torres E; Tam R; Kuan AJ; Morrow SA; Wilken J; Rauscher A; Bhan V; Sayao AL; Devonshire V; Li DKB; Carruthers R; Traboulsee A; Kolind SH
JAMA Netw Open; 2020 Sep; 3(9):e2014220. PubMed ID: 32990740
[TBL] [Abstract][Full Text] [Related]
39. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
[TBL] [Abstract][Full Text] [Related]
40. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
